Juno Therapeutics CEO: We're 'encouraged' by recent cancer trial results

9:57 AM ET Mon, 5 June 2017

Juno Therapeutics President & CEO Hans Bishop speaks with CNBC's Meg Tirrell from the ASCO conference on Monday.